MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
More news: Health / Surgery
Written by / Agency / Source: Leader Biomedical
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

ANVISA Approval for EMCM Facilitates the Progress of Leader Biomedical Operations in Brazil - Leader Biomedical's Dutch manufacturing facility in Nijmegen, European Medical Contract Manufacturing B.V. (EMCM) has received approval by the Brazilian competent authority, ANVISA - LeaderBiomedical.com
ANVISA Approval for EMCM Facilitates the Progress of Leader Biomedical Operations in Brazil

 

NewswireToday - /newswire/ - Amsterdam, North Holland, Netherlands, 2017/04/06 - Leader Biomedical's Dutch manufacturing facility in Nijmegen, European Medical Contract Manufacturing B.V. (EMCM) has received approval by the Brazilian competent authority, ANVISA - LeaderBiomedical.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Leader Biomedical is proud to announce that our manufacturing facility in Nijmegen, European Medical Contract Manufacturing B.V. (EMCM) has received approval by the Brazilian competent authority, Agência Nacional de Vigilância Sanitária (ANVISA). This approval follows the previously announced, ANVISA approval of our facilities in Brazil, Inovações Biológicas Comercial LTDA (Leader Biomedical Brazil), which validated the warehouse facilities and presence of technical staff, ensuring quality standards are met.

These approvals enable our Brazilian venture to fulfill critical milestones and allow Leader Biomedical Brazil to commercialise, distribute and store medical products and devices from class I through IV, which includes all medical products and provide the local region with access to our therapeutic solutions.

“This marks an important step for Leader Biomedical Brazil and EMCM. Since our establishment in 2016, we have been working diligently towards this milestone. Along with the help of our colleagues in the Netherlands, we have achieved the second part of this important certification and now look forward to improving access to our tried and tested bone cements in Brazil and allow for further expansion of our portfolio with orthobiologics and implants”, says Caio Gonçalves, general manager Inovações Biológicas Comercial LTDA

“Brazil is the largest medical device market in Latin America and has set a complex regulatory system as a barrier to entry in order to attest that the quality of the product meets expectations. As ANVISA requires registration request from a local entity, we have been working closely with the team in Brazil to provide all necessary documentation and proof of quality for our Dutch manufacturing facility” explains Arbër Gjunkshi, Regulatory Affairs Manager, Leader Biomedical.

The next and final step is the application with ANVISA for Leader Biomedical Brazil to obtain a legal manufacturing status and product registrations, all of which are scheduled in the coming months.

About Leader Biomedical

Leader Biomedical (leaderbiomedical.com) seeks to become a leader in the supply of biomaterials and surgical implants, improving global markets’ access to next generation technologies, and medical devices.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Leader Biomedical

 
 

PREMIUM Article / Social Media:

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health / Surgery articles,
CATCH Visitors via Your Competitors Announcements!


ANVISA Approval for EMCM Facilitates the Progress of Leader Biomedical Operations in Brazil

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Werner Schoeman - LeaderBiomedical.com 
+31(0)20 799 7793 media[.]leaderbiomedical.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Leader Biomedical securities in any jurisdiction including any other companies listed or named in this release.

Health / Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Leader Biomedical / Company Profile


Read Health / Surgery Most Recent Related Newswires:

Leader Biomedical Introduces Spine Portfolio with Targeted Therapeutic Solutions
Leader Biomedical Announces Acquisition of International Orthopaedics Holding GmbH
ANVISA Approval for EMCM Facilitates the Progress of Leader Biomedical Operations in Brazil
Leader Biomedical and Urogyn Collaborate to Bring Innovative New Procedure Urolastic™ to India
Leader Biomedical Group Enters APAC Market with New Offices in Malaysia
Leader Biomedical Launches Comprehensive Orthobiologics Portfolio
Leader Biomedical Group Partners with BioTiss Austria in New ECOO® Technology Venture
Leader Biomedical Group Establishes Operations in Brazil to Tap the Growing Biomaterials Market
Leader Biomedical Group Receives Approval to Distribute Bioresorbable Grafts in Switzerland
EMCM Contributes to Renal Cancer Treatment through VCC Medical NV Partnership
Leader Biomedical Group Opens Office in India

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  RightITnow, Inc.

Visit  BizJobs.com





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)